Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›ARPA-H Emerging Health Innovators (EHI) Initiative

U.S. Department Of Health And Human Services·District of Columbia

ARPA-H Emerging Health Innovators (EHI) Initiative

Closes 2/10/2027$350k – $1.1MRequest for Proposal
Get bids like this by emailBid source

Description

The ARPA‑H Emerging Health Innovators (EHI) Initiative solicits early‑career investigators to submit solution summaries (due Oct 30 2026) and, if encouraged, full proposals (due Feb 10 2027) for one of 16 cutting‑edge health‑focused topic areas ranging from skin‑level inflammation control to AI‑driven patient‑data privacy. Awards are structured as Other Transaction Agreements with a base performance period of 24 months (up to $1.05 M total) and an optional 12‑month “Director’s Award” extension. Proposers must be registered in SAM, identify a qualified Project Lead (≤ 8 years post‑terminal degree), and comply with extensive human/animal subject, IP, and security policies. Selected teams will receive up to $350 k per year, with milestones and deliverables defined in the Task Description Document. • Open to U.S.‑based entities (and eligible non‑U.S. entities under specific conditions) with a Unique Entity Identifier. • Must choose a single Topic Area; only one solution summary per proposer is allowed. • Solution summaries reviewed first; only “encouraged” proposals may proceed to full submission. • Funding up to $1,050,000 total (three $350 k NTE years). • Project Lead must be an early‑career researcher; other team members may include collaborators, sub‑awardees, or consultants. • Mandatory compliance with human subjects, animal subjects, CUI, OCI, and IP policies. • Award start anticipated June 30 2027; selection announced by April 30 2027.

Attached files

Contact

EHI Program Team

[email protected]

Key dates

Opened
9/25/2026
Questions due
2/3/2027
Closes
2/10/2027
Projected award
6/30/2027
Duration
24 months

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
ARPA-H-SOL-26-150

Budget estimate

$350,000 – $1,050,000

The solicitation caps the total award value at $1,050,000 per performer (three $350,000 NTE years). Most proposals will receive the full base period of 24 months ($700,000) with the possibility of a $350,000 optional extension, yielding a likely budget range of $350,000 (minimum for a single year) to $1,050,000 (full three‑year award). The exact amount will depend on the scope of work, milestone acceptance, and whether the optional Director’s Award is granted.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·District of Columbia

Top match · 97%

ARPA-H Emerging Health Innovators (EHI) Initiative

Closes 2/10/2027Opened 9/25/2026

U.S. National Institutes of Health·United States of America

81% match

NIH Director's New Innovator Award (DP2 Clinical Trial Optional)

Closes 8/18/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

80% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

80% match

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

Closes 4/28/2027Opened 4/26/2024

U.S. National Institutes of Health·United States of America

80% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

79% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

79% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. Department Of Health And Human Services·District of Columbia

79% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 6/8/2026

U.S. National Institutes of Health·United States of America

79% match

NIH Director's Early Independence Award (DP5 Clinical Trial Optional)

Closes 9/9/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

79% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. National Institutes of Health·United States of America

79% match

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Closes 11/10/2026Opened 6/25/2026

U.S. Department Of Health And Human Services·District of Columbia

79% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

79% match

NIH Director's Pioneer Award (DP1 Clinical Trial Optional)

Closes 9/8/2027Opened 9/3/2026

U.S. Department Of Health And Human Services·District of Columbia

78% match

Technology InteGrator and AcceleratoR (TIGAR)

Closes 12/8/2026Opened 4/22/2026

U.S. Bureau of Global Health Security and Diplomacy·United States of America

78% match

Advancing Global Health

Rolling / TBD closeOpened 8/18/2026

U.S. National Institutes of Health·United States of America

78% match

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

Closes 5/30/2029Opened 11/19/2025

U.S. Department Of Defense·Virginia

78% match

Expedited Research Innovation System (ERIS)

Closes 7/31/2027Opened 12/1/2024

U.S. National Institutes of Health·United States of America

78% match

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

78% match

R3PEATS Grassroots Rigor Projects: Individual Metascience and Individual Laboratory Capacity-Building (RP1)

Closes 9/30/2027Opened 9/11/2026

U.S. National Institutes of Health·United States of America

78% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

78% match

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Closes 9/25/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

78% match

Single Source: Institutional Development Award (IDeA) Clinical Research Resource Center (I-CRRC)

Closes 9/27/2027Opened 5/27/2026

U.S. National Institutes of Health·United States of America

78% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. Agency For International Development·United States of America

78% match

INNOVATIVE HEALTH PRACTICES

Closes 2/20/2028Opened 6/25/2024

U.S. National Institutes of Health·United States of America

78% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026